About WM Therapeutics
WM Therapeutics is a Healthcare company based in Heidelberg (Germany) founded in 2020. Small-molecule cancer therapeutics are developed to inhibit Warburg metabolism. The company has 12 employees. WM Therapeutics offers products and services including ISR Platform. Its focus areas include Life Sciences, Oncology, Drugs and Diversified. Its legal entity is WMT Aktiengesellschaft.
Company details
The company was founded in 2020 and is based in Heidelberg, Germany, within the biotechnology sector. Small-molecule therapies for cancer treatment are developed, targeting Warburg metabolism to reduce lactate production. This approach limits tumor growth and enhances immune system responses against tumors. Operations focus on innovative oncology solutions for potential clinical applications.
- Headquarters Heidelberg, Germany
- Employees 12
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website wm-therapeutics.com
- Social LinkedIn
- Legal Name Wmt Aktiengesellschaft
- Employee Count12
Products & Services of WM Therapeutics
WM Therapeutics offers a comprehensive portfolio of products and services, including ISR Platform.
Platform for developing cancer and inflammation treatments through research
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about WM Therapeutics
WM Therapeutics was founded in 2020.
WM Therapeutics is headquartered in Heidelberg, Germany. It is registered at Heidelberg, Baden-wurttemberg, Germany.
WM Therapeutics has 12 employees.
The company was founded in 2020 and is based in Heidelberg, Germany, within the biotechnology sector. Small-molecule therapies for cancer treatment are developed, targeting Warburg metabolism to reduce lactate production. This approach limits tumor growth and enhances immune system responses against tumors. Operations focus on innovative oncology solutions for potential clinical applications.
WM Therapeutics offers ISR Platform.
WM Therapeutics operates through Wmt Aktiengesellschaft.